Your browser doesn't support javascript.
loading
Adaptively leveraging external data with robust meta-analytical-predictive prior using empirical Bayes.
Zhang, Hongtao; Shen, Yueqi; Li, Judy; Ye, Han; Chiang, Alan Y.
Afiliação
  • Zhang H; Biostatistics and Research Decision Sciences, Merck & Co., Inc., North Wales, Pennsylvania, USA.
  • Shen Y; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Li J; GBDS, Bristol Myers Squibb, San Diego, California, USA.
  • Ye H; College of Business, Lehigh University, Bethlehem, Pennsylvania, USA.
  • Chiang AY; Biometrics, Lyell Immunopharma, Seattle, Washington, USA.
Pharm Stat ; 22(5): 846-860, 2023.
Article em En | MEDLINE | ID: mdl-37220997
ABSTRACT
The robust meta-analytical-predictive (rMAP) prior is a popular method to robustly leverage external data. However, a mixture coefficient would need to be pre-specified based on the anticipated level of prior-data conflict. This can be very challenging at the study design stage. We propose a novel empirical Bayes robust MAP (EB-rMAP) prior to address this practical need and adaptively leverage external/historical data. Built on Box's prior predictive p-value, the EB-rMAP prior framework balances between model parsimony and flexibility through a tuning parameter. The proposed framework can be applied to binomial, normal, and time-to-event endpoints. Implementation of the EB-rMAP prior is also computationally efficient. Simulation results demonstrate that the EB-rMAP prior is robust in the presence of prior-data conflict while preserving statistical power. The proposed EB-rMAP prior is then applied to a clinical dataset that comprises 10 oncology clinical trials, including the prospective study.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Modelos Estatísticos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Pharm Stat Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Modelos Estatísticos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Pharm Stat Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos